Lindsey Brendel, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 South St, Ridgway, PA 15853 Phone: 814-772-6850 |
Heidi Nicklas, MS.CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2873 State St, Ridgway, PA 15853 Phone: 814-834-4109 |
News Archive
Jonsson Cancer Center have discovered a novel anti-inflammatory cell signaling pathway that may serve as a vital Yin-Yang mechanism to maintain the delicate balance of immune response.
Researchers in the United States and Sweden have created personalized models of fetal brain microglia to investigate the effects of maternal infection on the developing brain, including infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
HaloSource, Inc., the clean water and antimicrobial technology company, today launches its line of finished devices for in home point-of-use water treatment, powered by HaloPure(R) drinking water disinfection technology.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
› Verified 4 days ago